Petros Pharmaceuticals, Inc. (NASDAQ:PTPI – Get Free Report)’s share price was down 5.8% on Friday . The stock traded as low as $0.32 and last traded at $0.33. Approximately 6,130,722 shares were traded during mid-day trading, an increase of 1,045% from the average daily volume of 535,337 shares. The stock had previously closed at $0.35.
Petros Pharmaceuticals Trading Down 5.8 %
The company’s fifty day moving average price is $0.32 and its two-hundred day moving average price is $0.37. The firm has a market cap of $3.30 million, a PE ratio of -0.07 and a beta of 1.99. The company has a quick ratio of 0.74, a current ratio of 0.85 and a debt-to-equity ratio of 1.58.
Petros Pharmaceuticals Company Profile
Petros Pharmaceuticals, Inc, a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED).
Further Reading
- Five stocks we like better than Petros Pharmaceuticals
- Conference Calls and Individual Investors
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- ESG Stocks, What Investors Should Know
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What Are the FAANG Stocks and Are They Good Investments?
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Petros Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petros Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
